Literature DB >> 25332968

Monitoring response to therapy in patients with cancer: is circulating DNA the answer?

Michael J Duffy1, John Crown1.   

Abstract

Entities:  

Year:  2013        PMID: 25332968      PMCID: PMC4200673          DOI: 10.3978/j.issn.2305-5839.2013.07.02

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  9 in total

1.  Sequence analysis of mutations and translocations across breast cancer subtypes.

Authors:  Shantanu Banerji; Kristian Cibulskis; Claudia Rangel-Escareno; Kristin K Brown; Scott L Carter; Abbie M Frederick; Michael S Lawrence; Andrey Y Sivachenko; Carrie Sougnez; Lihua Zou; Maria L Cortes; Juan C Fernandez-Lopez; Shouyong Peng; Kristin G Ardlie; Daniel Auclair; Veronica Bautista-Piña; Fujiko Duke; Joshua Francis; Joonil Jung; Antonio Maffuz-Aziz; Robert C Onofrio; Melissa Parkin; Nam H Pho; Valeria Quintanar-Jurado; Alex H Ramos; Rosa Rebollar-Vega; Sergio Rodriguez-Cuevas; Sandra L Romero-Cordoba; Steven E Schumacher; Nicolas Stransky; Kristin M Thompson; Laura Uribe-Figueroa; Jose Baselga; Rameen Beroukhim; Kornelia Polyak; Dennis C Sgroi; Andrea L Richardson; Gerardo Jimenez-Sanchez; Eric S Lander; Stacey B Gabriel; Levi A Garraway; Todd R Golub; Jorge Melendez-Zajgla; Alex Toker; Gad Getz; Alfredo Hidalgo-Miranda; Matthew Meyerson
Journal:  Nature       Date:  2012-06-20       Impact factor: 49.962

2.  Circulating tumor DNA--ready for prime time?

Authors:  Marc Lippman; C Kent Osborne
Journal:  N Engl J Med       Date:  2013-03-13       Impact factor: 91.245

Review 3.  CA 15-3: uses and limitation as a biomarker for breast cancer.

Authors:  Michael J Duffy; Denis Evoy; Enda W McDermott
Journal:  Clin Chim Acta       Date:  2010-09-08       Impact factor: 3.786

4.  Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer.

Authors:  Sarat Chandarlapaty; Rita A Sakr; Dilip Giri; Sujata Patil; Adriana Heguy; Monica Morrow; Shanu Modi; Larry Norton; Neal Rosen; Clifford Hudis; Tari A King
Journal:  Clin Cancer Res       Date:  2012-10-23       Impact factor: 12.531

5.  Analysis of circulating tumor DNA to monitor metastatic breast cancer.

Authors:  Sarah-Jane Dawson; Dana W Y Tsui; Muhammed Murtaza; Heather Biggs; Oscar M Rueda; Suet-Feung Chin; Mark J Dunning; Davina Gale; Tim Forshew; Betania Mahler-Araujo; Sabrina Rajan; Sean Humphray; Jennifer Becq; David Halsall; Matthew Wallis; David Bentley; Carlos Caldas; Nitzan Rosenfeld
Journal:  N Engl J Med       Date:  2013-03-13       Impact factor: 91.245

6.  National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.

Authors:  Catharine M Sturgeon; Michael J Duffy; Ulf-Håkan Stenman; Hans Lilja; Nils Brünner; Daniel W Chan; Richard Babaian; Robert C Bast; Barry Dowell; Francisco J Esteva; Caj Haglund; Nadia Harbeck; Daniel F Hayes; Mads Holten-Andersen; George G Klee; Rolf Lamerz; Leendert H Looijenga; Rafael Molina; Hans Jørgen Nielsen; Harry Rittenhouse; Axel Semjonow; Ie-Ming Shih; Paul Sibley; György Sölétormos; Carsten Stephan; Lori Sokoll; Barry R Hoffman; Eleftherios P Diamandis
Journal:  Clin Chem       Date:  2008-12       Impact factor: 8.327

7.  The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers.

Authors:  Luis A Diaz; Richard T Williams; Jian Wu; Isaac Kinde; J Randolph Hecht; Jordan Berlin; Benjamin Allen; Ivana Bozic; Johannes G Reiter; Martin A Nowak; Kenneth W Kinzler; Kelly S Oliner; Bert Vogelstein
Journal:  Nature       Date:  2012-06-28       Impact factor: 49.962

8.  PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib.

Authors:  Leiping Wang; Qunling Zhang; Jian Zhang; Si Sun; Haiyi Guo; Zhen Jia; Biyun Wang; Zhimin Shao; Zhonghua Wang; Xichun Hu
Journal:  BMC Cancer       Date:  2011-06-15       Impact factor: 4.430

9.  Comprehensive molecular portraits of human breast tumours.

Authors: 
Journal:  Nature       Date:  2012-09-23       Impact factor: 49.962

  9 in total
  1 in total

1.  Maintenance treatment of trastuzumab for patients with advanced breast cancer to achieve long term survival: two case reports and literature review.

Authors:  Min Yan; Hui-Min Lv; Meng-Wei Zhang; Shu-De Cui
Journal:  Chin J Cancer Res       Date:  2014-08       Impact factor: 5.087

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.